Global Opioid-Induced Constipation Market Size, Market Share, Industry Analysis Report 2026
2025年 12月 26日(金曜日) 15:50
On Dec 26, the latest report "Global Opioid-Induced Constipation Market 2026 by Manufacturers, Regions, Types and Applications, Forecast to 2032" from Global Info Research provides a detailed and comprehensive analysis of the global Opioid-Induced Constipation market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand trends, and key factors that are causing many market demand changes. The report also provides company profiles and product examples of some of the competitors, as well as market share estimates for some of the leading players in 2026.
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/3366520/opioid-induced-constipation
According to our (Global Info Research) latest study, the global Opioid-Induced Constipation market size was valued at US$ 2965 million in 2025 and is forecast to a readjusted size of USD million by 2032 with a CAGR of % during review period.
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
This report is a detailed and comprehensive analysis for global Opioid-Induced Constipation market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
Opioid-Induced Constipation market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Methylnaltrexone Bromide、 Lubiprostone、 Naloxegol、 Others
Market segment by Application: Hospital、 Pharmacy、 Other
Major players covered: Takeda Pharmaceuticals、 Bayer、 Sanofi、 Mallinckrodt、 Salix (Bausch Health)、 AstraZeneca、 Progenics Pharmaceuticals、 Purdue Pharm、 Nektar Therapeutics、 Daiichi Sankyo、 Prestige、 GSK、 Shionogi
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioid-Induced Constipation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Opioid-Induced Constipation, with price, sales quantity, revenue, and global market share of Opioid-Induced Constipation from 2021 to 2026.
Chapter 3, the Opioid-Induced Constipation competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid-Induced Constipation breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment Opioid-Induced Constipation the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the Opioid-Induced Constipation sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2025.and Opioid-Induced Constipation market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Opioid-Induced Constipation.
Chapter 14 and 15, to describe Opioid-Induced Constipation sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Opioid-Induced Constipation
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/3366520/opioid-induced-constipation
According to our (Global Info Research) latest study, the global Opioid-Induced Constipation market size was valued at US$ 2965 million in 2025 and is forecast to a readjusted size of USD million by 2032 with a CAGR of % during review period.
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
This report is a detailed and comprehensive analysis for global Opioid-Induced Constipation market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
Opioid-Induced Constipation market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Methylnaltrexone Bromide、 Lubiprostone、 Naloxegol、 Others
Market segment by Application: Hospital、 Pharmacy、 Other
Major players covered: Takeda Pharmaceuticals、 Bayer、 Sanofi、 Mallinckrodt、 Salix (Bausch Health)、 AstraZeneca、 Progenics Pharmaceuticals、 Purdue Pharm、 Nektar Therapeutics、 Daiichi Sankyo、 Prestige、 GSK、 Shionogi
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioid-Induced Constipation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Opioid-Induced Constipation, with price, sales quantity, revenue, and global market share of Opioid-Induced Constipation from 2021 to 2026.
Chapter 3, the Opioid-Induced Constipation competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid-Induced Constipation breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment Opioid-Induced Constipation the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the Opioid-Induced Constipation sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2025.and Opioid-Induced Constipation market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Opioid-Induced Constipation.
Chapter 14 and 15, to describe Opioid-Induced Constipation sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Opioid-Induced Constipation
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
登録者：giresearch1888
カテゴリー:
プレスリリース配信
